Supplementary folic acid associated with higher risk of COVID-19 diagnosis and mortality

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Supplementary folic acid associated with higher risk of COVID-19 diagnosis and mortality Foliccid Mortality Coronavirus Disease COVID Folate BMJ_Open otago ucdavis UABNews UQ_News

Study: Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case–control analysis from the UK Biobank. Image Credit: Pixel-Shot / Shutterstock

About the study The present study carried out a case-control analysis to determine the differential COVID-19 diagnosis and mortality risk associated with the use of folic acid supplements and methotrexate medications. The dataset obtained from the UK Biobank consisted of information from 380,380 participants who had been prescribed folic acid, methotrexate, anticonvulsants, iron supplements, and other medications such as statins.

Results The study results indicate a 1.5-fold increase in COVID-19 diagnosis risk and a 2.5-fold increase in COVID-19-related mortality risk associated with folic acid supplement prescriptions. Patients on prescribed methotrexate and folic acid supplements were not at increased risk of COVID-19 diagnosis or death, indicating that methotrexate could play an antagonistic role against the deleterious effect of folic acid in COVID-19 patients.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Two new trials find no link between vitamin D supplements and reduced risk of COVID-19Two large clinical trials published by The BMJ today show that boosting vitamin D levels in adults during the SARS-CoV-2 pandemic was not associated with protection against respiratory tract infections or COVID-19. bmj_latest COVID19 vitaminD The effects of infrared, UVA, UVB 24-hour cortisol-melatonin rhythm need to be measured. physorg_com bmj_latest Now tell us the health toll of people who took high doses of vitamin D early in the pandemic when the news said this would reduce their risk? bmj_latest BMJ (the company) receives revenues from drug and device manufacturers in the form of advertising, reprint sales, and sponsorship.
Source: medical_xpress - 🏆 101. / 51 Read more »